Distinguished Guest Lecture by Dr. Özlem Türeci: RNA-based therapeutics and personalized neoantigen cancer vaccines

Dr Özlem Türeci, co-founder and Clinical Medical Officer at BioNTech, gives a guest lecture at Oslo University Hospital on November 16 2023. Her talk on cancer vaccines and CAR-T is entitled "RNA-based therapeutics and personalized neoantigen cancer vaccines" and will be held in the Kaare Norum Auditorium at the Radium Hospital / CCC at 14.00. Please remember to register to this event!

‍

The guest lecture focuses on personalized cancer vaccines and Dr Özlem Türeci describes the content of this lecture as follows:

“My talk at the University will be a scientific, technological one directed to an expert scientific and clinical audience with strong background in immunology and oncology. I may cover 2 topics if time allows: preclinical-clinical development of RNA cancer vaccines and a new CAR T cell”.

‍

This event requires registration. Please register here!

Organizers: Institute for Cancer Research, CoE PRIMA and the Norwegian Society for Immunology. Contact: Kjetil Taskén and Johanna Olweus

For more background information on cancer vaccines:

• "Personalized RNA neoantigen vaccines stimulate T cells in pancreatic cancer", published in Nature in May 2023
• BioNTech iNeST Platform Concept

‍

Dr Özlem Türeci will on November 16 also give a second talk at The Norwegian Academy of Science and Letters on the development of the mRNA vaccine technology and the journey from cancer vaccines to the Pfizer/BioNTech Covid vaccines: "Vaccines: mRNA vaccine technology - Cancer, COVID-19 & beyond".